Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, R. J.
Right arrow Articles by Pledger, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, R. J.
Right arrow Articles by Pledger, W. J.
[Cancer Research 63, 3021-3025, June 15, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

p21Cip1 Nullizygosity Increases Tumor Metastasis in Irradiated Mice1

Rosalind J. Jackson2, Robert W. Engelman2, Domenico Coppola, Alan B. Cantor, Walker Wharton and W. Jack Pledger3

Molecular Oncology Program [R. J. J., W. W., W. J. P.], Pathology Service [D. C.], and Biostatistics and Informatics Core [A. B. C.], H. Lee Moffitt Cancer Center and Research Institute, and Departments of Interdisciplinary Oncology [R. J. J., D. C., W. W., W. J. P.], Pediatrics [R. W. E.], and Pathology and Laboratory Medicine [R. W. E.], University of South Florida College of Medicine, Tampa, Florida 33612

p21Cip1 is a cyclin-dependent kinase inhibitor whose abundance increases in cells exposed to radiation or other DNA-damaging agents. Such increases activate a G1 checkpoint, which allows time for DNA repair before S phase entry. By inhibiting cell cycle progression, p21Cip1 potentially suppresses tumorigenesis, and in support, we show that p21Cip1 heterozygous and nullizygous mice develop more tumors than do wild-type mice when exposed to a single dose of {gamma}-irradiation. Importantly, we also show that p21Cip1 nullizygosity increases the incidence of metastatic tumors in irradiated mice. We suggest that p21Cip1 is haploinsufficient for tumor suppression and functions as an antimetastatic agent.




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Cen, A. Deguchi, and I. B. Weinstein
Activation of Protein Kinase G Increases the Expression of p21CIP1, p27KIP1, and Histidine Triad Protein 1 through Sp1
Cancer Res., July 1, 2008; 68(13): 5355 - 5362.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. R. Payne and C. J. Kemp
Tumor suppressor genetics
Carcinogenesis, December 1, 2005; 26(12): 2031 - 2045.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
V. Devgan, C. Mammucari, S. E. Millar, C. Brisken, and G. P. Dotto
p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation
Genes & Dev., June 15, 2005; 19(12): 1485 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
P. Hauser, L. Ma, D. Agrawal, E. Haura, W. D. Cress, and W. J. Pledger
Efficient Down-Regulation of Cyclin A-Associated Activity and Expression in Suspended Primary Keratinocytes Requires p21Cip1
Mol. Cancer Res., February 1, 2004; 2(2): 96 - 104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.